13F filer · CIK 315066 ↗
Fidelity Investments
You are looking at Q1 2020. See the latest, Q2 2026 →
Reported value
$722.13B
−20% on the quarter before
Positions
4,149
419 new · 478 sold out
Top 10
26.5%
of the value
Est. gain
−$146.60B
on stocks held all quarter
Est. return
−18.0%
on those stocks since Q4 2019
Positions as of Mar 31, 2020, from Fidelity Investments's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
The 24 largest positions, 38% of the reported value, each sized by its share, colored by what the fund did with it since Q4 2019. Striped tiles are options.
Largest buys
Since Q4 2019, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Regeneron Pharmaceuticals~$2.56BAdded · 0.1% → 0.6%+5,238,483 shares
- Eli Lilly~$1.91BAdded · 0.2% → 0.5%+13,802,059 shares
- Ishares Tr~$919.5MAdded · 0.1% → 0.3%+3,558,343 shares
- Cigna Corp New~$806.1MAdded · 0.3% → 0.5%+4,549,842 shares
- Netflix~$669.3MAdded · 0.7% → 1.2%+1,782,375 shares
- Uber~$645.8MAdded · 0.2% → 0.3%+23,129,223 shares
- Vanguard Tax-Managed Intl Fd~$617.3MAdded · 0.0% → 0.1%+18,516,758 shares
- Nvidia~$605.0MAdded · 1.2% → 1.7%+2,295,180 shares
- Ishares Tr~$590.0MAdded · 0.1% → 0.2%+10,515,171 shares
- Alibaba~$556.9MAdded · 0.5% → 0.6%+2,863,693 shares
Largest sells
Since Q4 2019, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Amgen Inc~$1.39BCut · 0.7% → 0.5%−6,843,230 shares
- Berkshire Hathaway Inc Del~$1.12BCut · 0.5% → 0.3%−6,147,296 shares
- Stryker Corp~$1.12BCut · 0.3% → 0.1%−6,711,256 shares
- Comcast Corp New~$1.09BCut · 0.6% → 0.5%−31,830,386 shares
- Becton Dickinson & Co~$1.00BCut · 0.4% → 0.3%−4,358,272 shares
- Walt Disney Company (The)~$916.1MCut · 0.5% → 0.3%−9,483,713 shares
- PayPal~$890.4MCut · 0.7% → 0.7%−9,300,537 shares
- Ingersoll-Rand Plc~$860.5MSold out · 0.1% → 0.0%−6,474,165 shares
- Jpmorgan Chase & Co~$820.6MCut · 0.9% → 0.6%−9,114,541 shares
- Boston Scientific Corp~$801.8MCut · 0.6% → 0.5%−24,571,071 shares
Holdings
As of Mar 31, 2020. Changes are in shares against Dec 31, 2019, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| MicrosoftCOM · shares −0.5% · price +0.0% | 5.2% | $37.52B | +$2.4M | ||||||||
| AmazonCOM · shares +1.2% · price +5.5% | 4.3% | $30.88B | +$1.59B | ||||||||
| AppleCOM · shares −3.1% · price −13.4% | 3.3% | $23.74B | −$3.68B | ||||||||
| MetaCL A · shares +0.7% · price −18.7% | 2.9% | $20.72B | −$4.75B | ||||||||
| AlphabetCAP STK CL A · shares −4.9% · price −13.2% | 2.1% | $14.93B | −$2.28B | ||||||||
| Unitedhealth Group IncCOM · shares −2.3% · price −15.2% | 1.9% | $13.78B | −$2.47B | ||||||||
| Visa Inc.COM CL A · shares −4.1% · price −14.3% | 1.9% | $13.57B | −$2.26B | ||||||||
| SalesforceCOM · shares −1.6% · price −11.5% | 1.8% | $12.98B | −$1.68B | ||||||||
| NvidiaCOM · shares +5.1% · price +12.0% | 1.7% | $12.40B | +$1.27B | ||||||||
| AdobeCOM · shares −1.1% · price −3.5% | 1.5% | $11.17B | −$406.1M | ||||||||
| AlphabetCAP STK CL C · shares −6.4% · price −13.0% | 1.3% | $9.69B | −$1.45B | ||||||||
| MastercardCL A · shares −5.0% · price −19.1% | 1.3% | $9.30B | −$2.20B | ||||||||
| NetflixCOM · shares +8.7% · price +16.0% | 1.2% | $8.40B | +$1.07B | ||||||||
| Berkshire Hathaway Inc DelCL A · shares +0.3% · price −19.9% | 1.2% | $8.33B | −$2.06B | ||||||||
| Vertex Pharmaceuticals IncCOM · shares −5.0% · price +8.7% | 0.75% | $5.39B | +$430.5M | ||||||||
| Bk Of America CorpCOM · shares −13% · price −39.7% | 0.71% | $5.13B | −$3.38B | ||||||||
| General Electric CoCOM · shares −2.5% · price −28.9% | 0.68% | $4.93B | −$2.00B | ||||||||
| PayPalCOM · shares −16% · price −11.5% | 0.67% | $4.81B | −$624.2M | ||||||||
| AlibabaSPONSORED ADS · shares +14% · price −8.3% | 0.64% | $4.62B | −$368.0M | ||||||||
| Jpmorgan Chase & CoCOM · shares −16% · price −35.4% | 0.58% | $4.18B | −$2.29B | ||||||||
| Regeneron PharmaceuticalsCOM · shares +162% · price +30.0% | 0.57% | $4.13B | +$363.9M | ||||||||
| QualcommCOM · shares +5.0% · price −23.3% | 0.55% | $3.99B | −$1.16B | ||||||||
| Eli LillyCOM · shares +97% · price +5.5% | 0.54% | $3.89B | +$103.8M | ||||||||
| Bristol-Myers Squibb CoCOM · shares −4.7% · price −13.2% | 0.53% | $3.85B | −$583.1M | ||||||||
| Shopify IncCL A · shares −4.4% · price +5.4% | 0.51% | $3.68B | +$187.6M | ||||||||
| Total · 4,149 positions | 100% | $722.13B | −$146.60B |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q4 2019 to Q1 2020: 3,189 stocks held throughout, down $146.60B (−18.0%).
- Amazon+$1.59B+6%
- Nvidia+$1.27B+12%
- Netflix+$1.07B+16%
- Tesla+$487.7M+25%
- Vertex Pharmaceuticals Inc+$430.5M+9%
- Jpmorgan Chase & Co−$2.29B−35%
- Unitedhealth Group Inc−$2.47B−15%
- Bk Of America Corp−$3.38B−40%
- Apple−$3.68B−13%
- Meta−$4.75B−19%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out, 41 splits read into the share counts.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 13, 2026 | $2.30T+21% | SEC ↗ |
| Q1 2026 | May 15, 2026 | $1.90T−3% | SEC ↗ |
| Q4 2025 | Feb 17, 2026 | $1.96T+2% | SEC ↗ |
| Q3 2025 | Nov 13, 2025 | $1.92T+8% | SEC ↗ |
| Q2 2025 | Aug 14, 2025 | $1.77T+13% | SEC ↗ |
| Q1 2025 | May 12, 2025 | $1.57T−7% | SEC ↗ |
| Q4 2024 | Feb 13, 2025 | $1.68T+2% | SEC ↗ |
| Q3 2024 | Nov 13, 2024 | $1.64T+5% | SEC ↗ |
| Q2 2024 | Aug 13, 2024 | $1.56T+5% | SEC ↗ |
| Q1 2024 | May 13, 2024 | $1.49T+14% | SEC ↗ |
| Q4 2023 | Feb 13, 2024 | $1.30T+13% | SEC ↗ |
| Q3 2023 | Nov 13, 2023 | $1.16T−3% | SEC ↗ |
| Q2 2023 | Aug 11, 2023 | $1.19T−45% | SEC ↗ |
| Q1 2023 | May 11, 2023 (amended) | $2.19T+117% | SEC ↗ |
| Q4 2022 | Feb 13, 2023 | $1.01T+5% | SEC ↗ |
| Q3 2022 | Nov 10, 2022 | $958.93B−4% | SEC ↗ |
| Q2 2022 | Aug 12, 2022 | $1.00T−20% | SEC ↗ |
| Q1 2022 | May 13, 2022 | $1.25T−8% | SEC ↗ |
| Q4 2021 | Feb 14, 2022 | $1.35T+7% | SEC ↗ |
| Q3 2021 | Feb 14, 2022 (amended) | $1.26T−1% | SEC ↗ |
| Q2 2021 | Aug 13, 2021 | $1.28T+9% | SEC ↗ |
| Q1 2021 | May 14, 2021 | $1.17T+4% | SEC ↗ |
| Q4 2020 | Feb 8, 2021 | $1.12T+14% | SEC ↗ |
| Q3 2020 | Nov 13, 2020 | $989.33B+9% | SEC ↗ |
| Q2 2020 | Aug 24, 2020 (amended) | $909.48B+26% | SEC ↗ |
| Q1 2020 | May 14, 2020 | $722.13B−20% | SEC ↗ |
| Q4 2019 | Feb 7, 2020 | $906.40B+9% | SEC ↗ |
| Q3 2019 | Nov 13, 2019 | $833.77B−3% | SEC ↗ |
| Q2 2019 | Aug 13, 2019 | $856.19B+3% | SEC ↗ |
| Q1 2019 | May 13, 2019 (amended) | $834.93B+14% | SEC ↗ |
| Q4 2018 | Feb 13, 2019 (amended) | $730.25B−18% | SEC ↗ |
| Q3 2018 | Nov 9, 2018 | $888.88B+2% | SEC ↗ |
| Q2 2018 | Aug 10, 2018 (amended) | $868.68B+3% | SEC ↗ |
| Q1 2018 | May 14, 2018 | $842.35B−1% | SEC ↗ |
| Q4 2017 | Feb 12, 2018 | $853.06B+3% | SEC ↗ |
| Q3 2017 | Nov 13, 2017 | $827.12B+3% | SEC ↗ |
| Q2 2017 | Aug 29, 2017 (amended) | $804.55B+2% | SEC ↗ |
| Q1 2017 | May 11, 2017 | $787.10B+5% | SEC ↗ |
| Q4 2016 | Feb 10, 2017 (amended) | $748.25B−0% | SEC ↗ |
| Q3 2016 | Nov 14, 2016 | $750.86B+2% | SEC ↗ |
| Q2 2016 | Aug 11, 2016 | $732.58B+1% | SEC ↗ |
| Q1 2016 | May 16, 2016 | $722.80B | SEC ↗ |